Influence of Terminalia bellerica Roxb. fruit extracts on biochemical parameters in streptozotocin diabetic rats

International Journal of Pharmacology

Volumn 6, Issue 2, 2010, Pages 89-96

  Latha, R C R ^a   Daisy, P ^a  

^a HOLY CROSS COLLEGE   (India)

Author keywords

Antihyperglycemic; C peptide; Diabetic complications; Streptozotocin; Terminalia bellerica

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTIDIABETIC AGENT; C PEPTIDE; CREATININE; GLUCOSE; HEXANE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHANOL; PLANT EXTRACT; STREPTOZOCIN; TERMINALIA BELLERICA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; DYSLIPIDEMIA; FRUIT; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; TERMINALIA; TERMINALIA BELLERICA; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; WEIGHT GAIN; WISTAR RAT;

EID: 76549122652     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.89.96     Document Type: Article

References (46)

1. Almdal, J.P. and H. Vilstrup, 1988. Strict insulin therapy normalizes organ nitrogen contents and capacity of urea nitrogen synthesis in experimental diabetes in rats. Diabetlogia, 31: 114-118.
2. Anand, K.K., B. Singh, A.K. Saxena, B.K. Chandan and V.N. Gupta, 1994. Hepatoprotective studies of a fraction from the fruits of Terminalia bellerica Roxb. on experimental liver injury in rodents. Phytother. Res., 8: 287-292.
3. Anand, K.K., B. Singh, A.K. Saxena, B.K. Chandan, V.N. Gupta and V. Bhardwaj, 1997. 3,4,5-Trihydroxy benzoic acid (gallic acid), the hepatoprotective principle in the fruits of Terminalia bellerica-bioassay guided activity. Pharmacol. Res., 36: 315-321.
4. Anjana, J., B. Monika and S. Sangeeta, 2007. Protective effect of Terminalia belerica Roxb. and gallic acid against carbon tetrachloride induced damage in albino rats. J. Ethnopharmacol., 109: 214-218.
5. Chait, A. and J.D. Brunzell, 1996. Diabetes, Lipids and Atherosclerosis. In: Diabetes Mellitus, LeRoith, D., S.I. Taylor, J.M. Olefsky (Eds.). Lippincott-Raven Publishers, Philadelphia, pp: 467-469.
6. Chakravarti, M.D. and J.N. Tayal, 1947. Preliminary examination of the fruits of Terminalia belerica Roxb. Sci. Cult., 13: 122-126.
7. Chopra, R.N., S.L. Nayar and I.C. Chopra, 1996. Glossary of Indian Medicinal Plants. CSIR Publication, New Delhi, pp: 241.
8. Daisy, P., J. Eliza and S. Ignacimuthu, 2008. Influence of Costus speciosus (Koen.)Sm. Rhizome extracts on biochemical parameters in STZ induced Diabetic rats. J. Health Sci., 54: 675-681.
9. Daisy, P., R. Jasmine, S. Ignacimuthu and E. Murugan, 2009. A novel steroid from Elephantopus scaber L. an ethnomedicinal plant with antidiabetic activity. Phytomedicine, 16: 252-257.
10. Doda, R.F., 1996. Clinical Chemistry. Mosby Year Book, USA., pp: 613-641.
11. Gomes, A., J.R. Vedasiromoni, M. Das, R.M. Sharma and D.K. Ganguly, 2001. Anti-hyperglycaemic effect of black tea (Camellia sinensis) in rat. J. Ethnopharmacol., 27: 223-226.
12. Hansen, A., B. Johansson, J. Wahren and H. Von Bibra, 2002. C-Peptide exerts beneficial effects on myocardial blood flow and function in patients with Type 1 Diabetes. Diabetes, 51: 3077-3082.
13. Harborne, J.B., 1984. Phytochemical Methods. 2nd Edn., Chapman and Hall, London-New York.
14. Ido, Y., A. Vindigni, K. Chang, L. Stramm and R. Chance et al., 1997. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science, 277: 563-566.
15. Iwai, K., 2008. Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A mice. Plant Food Hum. Nutr., 63: 163-169.
16. Jasra, P.K. and C.L. Talesara, 1986. Effects of alloxan diabetes on innervated and denervated young rat muscles: A correlative histochemical, biochemical and electrophoretic study. Indian J. Exp. Biol., 24: 163-168.
17. Johansson, B.L., S. Sjoberg and J. Wahren, 1992. The influence of human C-peptide on renal function and glucose utilization in type 1(insulin-dependent) diabetic patients. Diabetologia, 35: 121-128.
18. Johansson, B.L., K. Borg, E. Fernqvist-Forbes, A. Kernell, T. Odergren and J. Wahren, 2000. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabetic Med., 17: 181-189.
19. Jones, P.J.H., D.E. MacDougall, F. Ntanios and C.A. Vanstone, 1997. Dietary phytosterols as cholesterol-lowering agents in humans. Can. J. Physiol. Pharm., 75: 217-227.
20. Kamiya, H., W. Zhang, K. Ekberg, J. Wahren and A.A.F. Sima, 2006. C-peptide reverses nociceptive neuropathy in type 1 diabetes. Diabetes, 55: 3581-3587.
21. Kaur, S., S. Arora, K. Kaur and S. Kumar, 2002. The in vitro antimutagenic activity of Triphala, an Indian herbal drug. Food Chem. Toxicol., 40: 527-534.
22. King, H., R.E. Aubert and W.H. Herman, 1998. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates and projections. Diabetes Care, 22: 1414-1431.
23. Kirtikar, K.R. and B.D. Basu, 1933. Terminalia (L.) 2: 2nd Indian Medicinal Plants. Lalit Mohan Basu, Allahabad, India, pp: 1014-1033.
24. Klein, G., J. Kim, K. Himmeldirk, Y. Cao and X. Chen, 2007. Antidiabetes and anti-obesity activity of Lagerstroemia speciosa. Evid-Based Complementary Alternative Med., 4: 401-407.
25. Latte, K. and H. Kolodziej, 2004. Antioxidant properties of phenolic compounds from pelargonium reniforme. J. Agric. Food Chem., 52: 4899-4902.
26. Marques, R.G., M.J. Fontaine and J. Rogers, 2004. C-peptide: Much more than a byproduct of insulin biosynthesis. Pancreas, 29: 231-238.
27. Mauer, S.M., M.W. Steffes and D.M. Brown, 1981. The kidney in diabetes. Am. Med., 70: 603-612.
28. Nadkarni, A.K., 1954. Dr. K.M. Nadkarnis Indian Materia Medica. 3rd Edn., Popular Book Depot, Bombay, India, pp: 1202.
29. Nakhoda, A. and H.A. Wong, 1979. The induction of diabetes in rats by intramuscular administration of streptozotocin. Experientia, 35: 1679-1680.
30. Nandy, A.K., G. Podder, N.P. Sahu and S.B. Mahato, 1989. Triterpenoids and their glucosides from Terminalia Bellerica. Phytochemistry, 28: 2769-2112.
31. Reinhold, J., 1980. Determination of Serum Total Protein, Albumin and Globulin Fractions by the Biuret Method. In: Practical Clinical Biochemistry, Varley, H., A.H. Gowen Lock and M. Bell (Eds.). 5th Edn., William Heinemann Medical Book Ltd., London, pp: 545-547.
32. Row, L.R. and P.S. Murty, 1970. Chemical examination of Terminalia bellerica Roxb. Indian J. Chem., 8: 1047-1048.
33. Sabu, M.C. and R. Kuttan, 2002. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J. Ethanopharmacol., 81: 155-160.
34. Samnegård, B., S.H. Jacobson, G. Jaremko, B. Johansson and K. Ekberg et al., 2005. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol. Dial. Transpl., 20: 532-538.
35. Shaila, H.P., A.L. Udupa and S.L. Udupa, 1995. Preventive actions of Terminalia bellerica in experimentally induced atherosclerosis. Int J. Cardiol., 49: 101-106.
36. Siddiqui, H.N., 1963. Studies on Terminalia bellerica Roxb. Effect on bile secretion and pharmacodynamic properties. Indian J. Pharmacol., 25: 297-302.
37. Srivastava, R.D., S. Dwivedi, K.K. Sreenivasan and C.N. Chandrashekhar, 1992. Cardiovascular effects of Terminalia species of plants. Indian Drugs, 29: 144-149.
38. Tariq, M., S.J. Hussain, M. Asif and M. Jahan, 1977. Protective effect of fruit extracts of Emblica officinalis (Gaertn) Terminalia bellerica (Roxb.) in experimental myocardial necrosis in rats. Indian J. Exp. Biol., 15: 485-486.
39. Tchobroutsky, G., 1978. Relation of diabetic control to development of microvascular complications. Diabetologia, 15: 143-152.
40. Thakur, C.P., B. Thakur, S. Singh, P.K. Sinha and S.K. Sinha, 1988. The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol induced atherosclerosis in rabbits. Int. J. Cardiol., 21: 167-175.
41. Trease, G.E. and W.C. Evans, 1994. Pharmacognosy. 13th Edn., University Press, Great Britain, Cambridge, pp. 247-264.
42. Trinder, P., 1969. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann. Clin. Biochem., 6: 24-27.
43. Trivedi, V.P., S. Nesamany and V.K. Sharma, 1979. A clinical study of the anti-tussive and anti-asthmatic effects of Vibhitakphal Churna (Terminalia bellerica Roxb.) in the cases of Kasa-Swasa. J. Res. Ayurveda Siddha, 3: 1-8.
44. Valiathan, M.S., 1998. Healing plant. Curr. Sci., 75: 1122-1126.
45. Valsaraj, R., P. Pushpangadan, U.W. Smitt, A. Adsersen and S.B. Christensen et al., 1997. New anti-HIV-1, antimalarial and antifungal compounds from Terminalia bellerica. J. Nat. Prod., 60: 739-742.
46. Yadava, R.N. and K. Rathore, 2001. A new cardenolide from the seeds of Terminalia bellerica. Pitoterapia, 72: 310-312.